| Literature DB >> 27965253 |
Bjørg Karlsen1, Bjørg Oftedal1, Silje Stangeland Lie1, Berit Rokne2, Mark Peyrot3, Vibeke Zoffmann4, Marit Graue5.
Abstract
INTRODUCTION: Self-management is deemed the cornerstone in overall diabetes management. Web-based self-management interventions have potential to support adults with type 2 diabetes (T2DM) in managing their disease. Owing to somewhat ambiguous results of such interventions, interventions should be theory-based and incorporate well-defined counselling methods and techniques for behavioural change. This study is designed to assess the effectiveness of a theory-driven web-based Guided Self-Determination (GSD) intervention among adults with T2DM in general practice to improve diabetes self-management behaviours and glycosylated haemoglobin (HbA1c). METHODS AND ANALYSIS: A complex intervention design based on the framework of the UK Medical Research Council is employed as a guide for developing the intervention, assessing its feasibility and evaluating its effectiveness. The study consists of three phases: (1) the modelling phase adapting the original GSD programme for adults with T2DM, using a qualitative design, (2) feasibility assessment of the adapted intervention on the web, employing qualitative and quantitative methods and (3) evaluating the effectiveness of the intervention on diabetes self-management behaviours and HbA1c, using a quasi-experimental design. The first phase, which is completed, and the second phase, which is underway, will provide important information about the development of the intervention and its acceptability, whereas the third phase will assess the effectiveness of this systematically developed intervention. ETHICS AND DISSEMINATION: The Norwegian Regional Committee for Medical and Health Research Ethics (REK west number 2015/60) has approved the study design. Patients recruited in the different phases will fill out an informed consent form prior to inclusion and will be guaranteed anonymity and the right to withdraw from the study at any time. The results of the study will be published in peer-reviewed journals, electronically and in print, and presented at research conferences. TRIAL REGISTRATION NUMBER: NCT02575599. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.Entities:
Keywords: DIABETES & ENDOCRINOLOGY; MEDICAL EDUCATION & TRAINING; PRIMARY CARE
Mesh:
Substances:
Year: 2016 PMID: 27965253 PMCID: PMC5168684 DOI: 10.1136/bmjopen-2016-013026
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Study overview
| Phases | Aims | Methods | Participants |
|---|---|---|---|
| Phase 1. | Qualitative approaches with individual interviews in both steps, using qualitative content analysis. | ||
| Phase 2. | Pretesting the adapted GSD intervention on the web and assessing its feasibility. | Quantitative: Pre–post design. | 40 patients with T2DM who have participated in the web-based GSD adapted for T2DM will be recruited from GPs. |
| Phase 3. | Evaluating the effectiveness of a structured theory-driven web-based GSD intervention on self-management behaviours and HbA1c. | Quasi-experimental design with outcome assessments at baseline, end of programme and 6-month postprogramme. | A total of 172 patients with T2DM will be recruited from GPs (intervention group n=86, control group n=86). |
GP, general practitioners; GSD, Guided Self-Determination; HbA1c, glycosylated haemoglobin; T2DM, type 2 diabetes.
The GSD adapted to T2DM
| The first session | Preparing for subsequent consultations: |
|---|---|
| Consultations: | Reflection sheets (RS) |
| Your life with diabetes | RS 1a. Important events and periods in your life |
| Focus for change | RS 2a. Room for diabetes in your life |
| Work with changes | RS 3a. Clarification of challenge in your life with diabetes |
| Changes in daily life | RS 4a. Blood sugar checks and your reasons for checking |
GSD, Guided Self-Determination; HbA1c, glycosylated haemoglobin; T2DM, type 2 diabetes.